|
|
Volumn 9, Issue 4, 2006, Pages
|
|
Lower is better--the contemporary concept of low-density lipoprotein lowering in the preventive management of cardiovascular risk: does this apply to all patients?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTILIPEMIC AGENT;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN;
AGE;
BLOOD;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG EFFECT;
HUMAN;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIMARY PREVENTION;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RISK FACTOR;
RISK MANAGEMENT;
SEX DIFFERENCE;
AGE FACTORS;
ANTILIPEMIC AGENTS;
CARDIOVASCULAR DISEASES;
DIABETES MELLITUS, TYPE 2;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
LIPOPROTEINS, LDL;
PRIMARY PREVENTION;
RANDOMIZED CONTROLLED TRIALS;
RISK FACTORS;
RISK MANAGEMENT;
SEX FACTORS;
|
|
EID: 39049180291
PISSN: 1520037X
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1520-037X.2006.05324.x Document Type: Review |
|
Times cited : (1)
|
|
References (54)
|
